(34.238.189.240)
Users online: 1900    [ij] [ij] [ij] 
Email id
 

RESEARCH JOURNAL OF PHARMACY AND TECHNOLOGY
Year : 2021, Volume : 14, Issue : 2
First page : ( 925) Last page : ( 930)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2021.00165.7

A RP-HPLC method development and validation for simultaneous estimation of imipenem, cilastatin and relebactum in API and in pharmaceutical lyophilized powder for injection

Dr. Swapna K.1, Dr. Deepthi K.2, Padmini T.3*

1Sphoorthy Engineering College, Nadergul, Sagar Road, Saroornagr, R. R. (Dist) Telangana State, 501510.

2Mahaveer Institute of Science and Technology, Vyasapuri, Bandlaguda, Hyderabad.

3Assistant Professor, Megha Institute of Engineering and Technology for Women. Edulabad, Ghatkesar, Hyderabad

*Corresponding Author E-mail: paddu2505@gmail.com

Online published on 30 April, 2021.

Abstract

An accurate, sensitive, precise, rapid and isocratic RP-HPLC method for simultaneous estimation of Cilastatin, Imipenem and Relebactum in the bulk drug and in pharmaceutical metered dose inhalers is developed and validated. The best separation achieved on Hypersil BDS Reverse Phase-C18 column (250mm × 4.6 x 5-μm) with acetonitrile as the organic modifier and dipotassium hydrogen phosphate [0.03M] in water with pH 3.2 adjusted with ortho-phosphoric acid (0.1% v/v) as mobile phase at a flow rate of 1.0mL min−1. UV detection carried out at 265nm. Retention times observed at 3.107 min. for Imipenem, 3.885 min. for Cilastatin and 10.516 min for Relebactum. A linear response observed at concentration range of 20–120 mcg/ml for Cilastatin, 20-120mcg/ml for Imipenem and 10–60 mcg/ml for Relebactum respectively with average correlation coefficient of > 0.999. The percentage assay for Cilastatin, Imipenem and Relebactum were found 98.37, 99.72 and 99.18% respectively. The limit of detection (LOD) was found to be 0.01μg/mL for Cilastatin, 0.02μg/mL for Imipenem and 0.05μg/mL for Relebactum. The limit of Quantification found to be 0.03μg/mL, 0.06μg/mL and 0.15μg/mL for Cilastatin, Imipenem and Relebactum respectively. The excipients present in the formulation did not interfere with the assay procedure. The method is suitable for application in quality-control laboratories, because it is simple and rapid with good accuracy and precision.

Top

Keywords

Cilastatin, Imipenem and Relebactum, Gradient RP-HPLC, And Lyophilized sterile powder for injection, And Recarbrio®.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
625,887,319 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.